YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m6A-dependent manner

被引:50
作者
Lin, Yuxiang [1 ,2 ,3 ]
Jin, Xuan [1 ,2 ,3 ]
Nie, Qian [1 ,2 ,3 ]
Chen, Minyan [1 ,2 ,3 ]
Guo, Wenhui [1 ,2 ,3 ]
Chen, Lili [1 ,2 ,3 ]
Li, Yan [1 ,2 ,3 ]
Chen, Xiaobin [1 ,2 ,3 ]
Zhang, Wenzhe [1 ,2 ,3 ]
Chen, Hanxi [1 ,2 ,3 ]
Jiang, Meichen [4 ]
Xiao, Han [4 ]
Zhang, Jie [1 ,2 ,3 ]
Fu, Fangmeng [1 ,2 ,3 ]
Wang, Chuan [1 ,2 ,3 ]
机构
[1] Fujian Med Univ, Dept Breast Surg, Union Hosp, 29 Xin Quan Rd, Fuzhou 350001, Peoples R China
[2] Fujian Med Univ, Dept Gen Surg, Union Hosp, Fuzhou, Peoples R China
[3] Fujian Med Univ, Breast Canc Inst, Fuzhou, Peoples R China
[4] Fujian Med Univ, Dept Pathol, Union Hosp, Fuzhou, Peoples R China
关键词
Triple-negative breast cancer (TNBC); metastasis; epithelial-mesenchymal transition (EMT); YTH domain family 3 (YTHDF3); zinc finger E-box-binding homeobox 1 (ZEB1); METHYLTRANSFERASE METTL3 PROMOTES; EMT-ACTIVATOR ZEB1; CELL PLASTICITY; TRANSLATION; STEMNESS;
D O I
10.21037/atm-21-6857
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The YTH domain family protein 3 (YTHDF3) is an important N6-methyladenosine (m(6)A) reader which is involved in multiple cancers. However, the biological role and mechanisms of action for YTHDF3 in triple-negative breast cancer (TNBC) remains to be elucidated. Methods: The expression of YTHDF3 in TNBC tissues was evaluated using The Cancer Genome Atlas (TCGA) database, BC-GenExMiner, and immunohistochemistry (IHC) staining. Cell migration, invasion, and epithelial-mesenchymal transition (EMT) were validated by wound healing assays, transwell assays, and Western blot (WB) analyses. The association between YTHDF3 and zinc finger E-box-binding homeobox 1 (ZEB1) was confirmed by Pearson correlation analysis. RNA-binding protein immunoprecipitation (RIP) assays and mRNA actinomycin stability analyses were applied to confirm whether YTHDF3 could interact with ZEB1in an m(6)A-dependent manner. Results: The expression of YTHDF3 was correlated with poorer disease-free survival (DFS) and overall survival (OS) in TNBC patients. Functional experiments indicated that YTHDF3 positively regulated cell migration, invasion, and EMT in TNBC cells. Moreover, ZEB1 was identified as a key downstream target for YTHDF3 and YTHDF3 could enhance ZEB1 mRNA stability in an m(6)A-dependent manner. Inhibition of YTHDF3 reduced migration, invasion, and EMT, all of which were reversed by rescue experiments overexpressing ZEB1. Conclusions: The findings herein confirmed that the YTHDF3/ZEB1 axis plays an important role in the progression and metastasis of TNBC. YTHDF3 is a promising prognosis biomarker and potential therapeutic target for patients with TNBC.
引用
收藏
页数:15
相关论文
共 45 条
[1]  
Anita R, 2020, AM J CANCER RES, V10, P2546
[2]   Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma [J].
Bian, Saiyan ;
Ni, Wenkai ;
Zhu, Mengqi ;
Song, Qianqian ;
Zhang, Jianping ;
Ni, Runzhou ;
Zheng, Wenjie .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
[3]   Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease [J].
Bianchini, Giampaolo ;
Balko, Justin M. ;
Mayer, Ingrid A. ;
Sanders, Melinda E. ;
Gianni, Luca .
NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (11) :674-690
[4]   Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials [J].
Boddington, C. ;
Bradley, R. ;
Braybrooke, J. ;
Burrett, J. ;
Clarke, M. ;
Davies, C. ;
Davies, L. ;
Dodwell, D. ;
Duane, F. ;
Evans, V. ;
Gettins, L. ;
Godwin, J. ;
Gray, R. ;
Hills, R. ;
James, S. ;
Liu, H. ;
Liu, Z. ;
MacKinnon, E. ;
Mannu, G. ;
McGale, P. ;
McHugh, T. ;
Morris, P. ;
Pan, H. ;
Peto, R. ;
Read, S. ;
Taylor, C. ;
Wang, Y. ;
Wang, Z. ;
Bradley, R. ;
Braybrooke, J. ;
Gray, R. ;
Bergh, J. ;
Peto, R. ;
Gray, Richard ;
Bradley, Rosie ;
Braybrooke, Jeremy ;
Liu, Zulian ;
Peto, Richard ;
Davies, Lucy ;
Dodwell, David ;
McGale, Paul ;
Pan, Hongchao ;
Taylor, Carolyn ;
Barlow, William ;
Bliss, Judith ;
Bruzzi, Paolo ;
Cameron, David ;
Fountzilas, George ;
Loibl, Sibylle ;
Mackey, John .
LANCET, 2019, 393 (10179) :1440-1452
[5]   SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer [J].
Budd, George T. ;
Barlow, William E. ;
Moore, Halle C. F. ;
Hobday, Timothy J. ;
Stewart, James A. ;
Isaacs, Claudine ;
Salim, Muhammad ;
Cho, Jonathan K. ;
Rinn, Kristine J. ;
Albain, Kathy S. ;
Chew, Helen K. ;
Burton, Gary V. ;
Moore, Timothy D. ;
Srkalovic, Gordan ;
McGregor, Bradley A. ;
Flaherty, Lawrence E. ;
Livingston, Robert B. ;
Lew, Danika L. ;
Gralow, Julie R. ;
Hortobagyi, Gabriel N. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (01) :58-U95
[6]   Pleiotropic Roles for ZEB1 in Cancer [J].
Caramel, Julie ;
Ligier, Maud ;
Puisieux, Alain .
CANCER RESEARCH, 2018, 78 (01) :30-35
[7]   Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity [J].
Chaffer, Christine L. ;
Marjanovic, Nemanja D. ;
Lee, Tony ;
Bell, George ;
Kleer, Celina G. ;
Reinhardt, Ferenc ;
D'Alessio, Ana C. ;
Young, Richard A. ;
Weinberg, Robert A. .
CELL, 2013, 154 (01) :61-74
[8]   YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis [J].
Chang, Guoqiang ;
Shi, Lei ;
Ye, Youqiong ;
Shi, Hailing ;
Zeng, Lixian ;
Tiwary, Shweta ;
Huse, Jason T. ;
Huo, Lei ;
Ma, Li ;
Ma, Yongjie ;
Zhang, Sicong ;
Zhu, Jianwei ;
Xie, Victoria ;
Li, Peng ;
Han, Leng ;
He, Chuan ;
Huang, Suyun .
CANCER CELL, 2020, 38 (06) :857-+
[9]   N6-Methyladenosine Regulates mRNA Stability and Translation Efficiency of KRT7 to Promote Breast Cancer Lung Metastasis [J].
Chen, Feng ;
Chen, Zhuojia ;
Guan, Tao ;
Zhou, Yan ;
Ge, Lichen ;
Zhang, Haisheng ;
Wu, Yingmin ;
Jiang, Guan-Min ;
He, Weiling ;
Li, Jiexin ;
Wang, Hongsheng .
CANCER RESEARCH, 2021, 81 (11) :2847-2860
[10]   The role of m6A RNA methylation in human cancer [J].
Chen, Xiao-Yu ;
Zhang, Jing ;
Zhu, Jin-Shui .
MOLECULAR CANCER, 2019, 18 (1)